Search research articles
Contact Us
Filters
Showing results (61-70 of 115) with videos related to
Page
of 12
Sort By:
The Journal of Hospital Infection
|
March 15, 2022
Airborne SARS-CoV-2 RNA excretion by patients with COVID-19 on different oxygen-delivery systems: a prospective observational study
M L Janssen, Y P Klazen, P de Man, et al.
European Journal of Cancer & Clinical Oncology
|
November 1, 1985
cis-Platinum as second-line chemotherapy in advanced gastric adenocarcinoma. A phase II study of the EORTC Gastrointestinal Tract Cancer Cooperative Group
A J Lacave, J Wils, E Diaz-Rubio, et al.
Andrology
|
May 28, 2015
Assessment of the optimal vitrification protocol for pre-pubertal mice testes leading to successful in vitro production of flagellated spermatozoa
L Dumont, B Arkoun, F Jumeau, et al.
Cancer Investigation
|
January 1, 1990
Randomized phase II study of a combination of cisplatin (DDP), 5-fluorouracil (5-FU), and allopurinol (HPP) versus 5-FU in advanced colorectal carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group study
H Bleiberg, B Vanderlinden, M Buyse, et al.
British Journal of Cancer
|
May 1, 1988
The prognostic value of morphometrical features and cellular DNA content in cis-platin treated late ovarian cancer patients
J P Baak, N W Schipper, E C Wisse-Brekelmans, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 3, 2004
Weekly high-dose 5-fluorouracil and folinic acid in metastatic pancreatic carcinoma: a phase II study of the EORTC GastroIntestinal Tract Cancer Cooperative Group
R E N Van Rijswijk, K Jeziorski, D J Th Wagener, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1995
Adjuvant chemo-hormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate for node-positive cancer patients. Update at 7-year follow-up
P Hupperets, J Wils, L Volovics, et al.
Bulletin Du Cancer
|
March 1, 1993
[Combination of 5-FU, high dose methotrexate, epirubicin and cisplatin (FEMTX-P protocol) in non surgical or locally recurrent metastatic gastric cancers]
T Conroy, J Wils, B Paillot, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
January 20, 2017
l-Lysine Acts as a Serotonin Type 4 Receptor Antagonist to Counteract In Vitro and In Vivo the Stimulatory Effect of Serotonergic Agents on Aldosterone Secretion in Man
C Duparc, C André, J Ménard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1986
Primary or delayed debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide in stage III-IV epithelial ovarian carcinoma
J Wils, G Blijham, A Naus, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 115) with videos related to
Sort By:
Page
of 12
The Journal of Hospital Infection
|
March 15, 2022
Airborne SARS-CoV-2 RNA excretion by patients with COVID-19 on different oxygen-delivery systems: a prospective observational study
M L Janssen, Y P Klazen, P de Man, et al.
European Journal of Cancer & Clinical Oncology
|
November 1, 1985
cis-Platinum as second-line chemotherapy in advanced gastric adenocarcinoma. A phase II study of the EORTC Gastrointestinal Tract Cancer Cooperative Group
A J Lacave, J Wils, E Diaz-Rubio, et al.
Andrology
|
May 28, 2015
Assessment of the optimal vitrification protocol for pre-pubertal mice testes leading to successful in vitro production of flagellated spermatozoa
L Dumont, B Arkoun, F Jumeau, et al.
Cancer Investigation
|
January 1, 1990
Randomized phase II study of a combination of cisplatin (DDP), 5-fluorouracil (5-FU), and allopurinol (HPP) versus 5-FU in advanced colorectal carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group study
H Bleiberg, B Vanderlinden, M Buyse, et al.
British Journal of Cancer
|
May 1, 1988
The prognostic value of morphometrical features and cellular DNA content in cis-platin treated late ovarian cancer patients
J P Baak, N W Schipper, E C Wisse-Brekelmans, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 3, 2004
Weekly high-dose 5-fluorouracil and folinic acid in metastatic pancreatic carcinoma: a phase II study of the EORTC GastroIntestinal Tract Cancer Cooperative Group
R E N Van Rijswijk, K Jeziorski, D J Th Wagener, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1995
Adjuvant chemo-hormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate for node-positive cancer patients. Update at 7-year follow-up
P Hupperets, J Wils, L Volovics, et al.
Bulletin Du Cancer
|
March 1, 1993
[Combination of 5-FU, high dose methotrexate, epirubicin and cisplatin (FEMTX-P protocol) in non surgical or locally recurrent metastatic gastric cancers]
T Conroy, J Wils, B Paillot, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
January 20, 2017
l-Lysine Acts as a Serotonin Type 4 Receptor Antagonist to Counteract In Vitro and In Vivo the Stimulatory Effect of Serotonergic Agents on Aldosterone Secretion in Man
C Duparc, C André, J Ménard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1986
Primary or delayed debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide in stage III-IV epithelial ovarian carcinoma
J Wils, G Blijham, A Naus, et al.
Page
of 12